[Federal Register Volume 62, Number 163 (Friday, August 22, 1997)]
[Notices]
[Page 44699]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-22470]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Vaccine Advisory Committee

    National Vaccine Advisory Committee (NVAC), Subcommittee on Vaccine 
Safety, Subcommittee on Immunization Coverage, Subcommittee on Future 
Vaccines, and the Advisory Commission on Childhood Vaccines (ACCV) 
Subcommittee on Vaccine Safety: Meetings.
    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Federal advisory committee 
meetings.

    Name: National Vaccine Advisory Committee (NVAC).
    Times and Dates: 9 a.m.-12:30 p.m., September 8, 1997; 8:30 
a.m.-12 noon, September 9, 1997.
    Place: Hubert H. Humphrey Building, Room 303A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Notice: In the interest of security, the Department has 
instituted stringent procedures for entrance to the Hubert H. 
Humphrey Building by non-government employees. Thus, persons without 
a government identification card should plan to arrive at the 
building each day either between 8 and 8:30 a.m. or 12:30 and 1 p.m. 
so they can be escorted to the meeting. Entrance to the meeting at 
other times during the day cannot be assured.
    Purpose: This committee advises and makes recommendations to the 
Director of the National Vaccine Program on matters related to the 
Program responsibilities.
    Matters To Be Discussed: Agenda items will include a National 
Vaccine Program Office (NVPO) update; discussions on immunization 
coverage: Strategies to sustain success; accountability for 
immunization: Closing the gaps; immunization registries: Workshop 
plans; vaccine safety datalink: Local and national perspectives; 
surveillance for adverse events following vaccination: Options for 
funding; mucosal vaccines: Status, potential and current research; 
utilization of non-traditional sites for adult immunization; IPV/
OPV: Impact of revised recommendations on coverage; clarifying 
harmonization of package labeling and recommendations of advisory 
groups. There will be an update on plans to address concerns 
following the Edmonston-Zagreb Measles Vaccine Investigation in Los 
Angeles, California. Also, there will be reports from the work group 
on philosophic objections; reports from the Subcommittee on 
Immunization Coverage; Subcommittee on Future Vaccines; and the 
Subcommittee on Vaccine Safety.

    Name: Subcommittee on Immunization Coverage.
    Time and Date: 1:30 p.m.-5 p.m., September 8, 1997.
    Place: Hubert H. Humphrey Building, Room 423A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee will identify and propose solutions 
that provide a multifaceted and holistic approach to reducing 
barriers that result in low immunization coverage for children.
    Matters To Be Discussed: This subcommittee will hold a 
discussion on the review of recommendations from the document, 
``Strategies to Sustain Immunization Coverage'', and the 
finalization of those recommendations.

    Name: Subcommittee on Future Vaccines.
    Time And Date: 1:30 p.m.-5 p.m., September 8, 1997.
    Place: Hubert H. Humphrey Building, Room 405A, 00 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: The Subcommittee on Future Vaccines will develop policy 
options and guide national activities which will lead to accelerated 
development, licensure, and best use of new vaccines in the simplest 
possible immunization schedules.
    Matters To Be Discussed: This subcommittee will hold discussions 
regarding the Cold Spring Harbor Report; combination vaccines, 
strategic options; and defining future vaccines policy issues for 
traveler's vaccines.

    Name: Subcommittee on Vaccine Safety and the Advisory Commission 
on Childhood Vaccines, Subcommittee on Vaccine Safety.
    Time And Date: 1:15 p.m.-4:45 p.m., September 9, 1997.
    Place: Hubert H. Humphrey Building, Room 303A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This joint NVAC/ACCV subcommittee will review issues 
relevant to vaccine safety and adverse reactions to vaccines.
    Matters To Be Discussed: This subcommittee will hold discussions 
regarding the vaccine safety subcommittee goals; a report from the 
Task Force on Safer Childhood Vaccines; a project report on benefit-
risk communication curriculum development; and agenda items for next 
meeting.
    Agenda items are subject to change as priorities dictate.
    Contact Person For More Information: Felecia D. Pearson, 
Committee Management Specialist, NVPO, CDC, 1600 Clifton Road, NE, 
M/S D50, Atlanta, Georgia 30333, telephone 404/639-7250.

    Dated: August 18, 1997.
Nancy C. Hirsch,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 97-22470 Filed 8-21-97; 8:45 am]
BILLING CODE 4163-18-P